Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees
- Jens Bukh*,†,
- Thomas Pietschmann‡,§,
- Volker Lohmann‡,§,
- Nicole Krieger‡,§,
- Kristina Faulk*,
- Ronald E. Engle*,
- Sugantha Govindarajan¶,
- Max Shapiro∥,
- Marisa St. Claire∥, and
- Ralf Bartenschlager‡,§
- *Hepatitis Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892; ‡Institute for Virology, Johannes Gutenberg University, Mainz 55131, Germany;§ Department of Molecular Virology, Institute of Hygiene, University of Heidelberg, Heidelberg 69120, Germany;¶ Liver Research Laboratory, Rancho Los Amigos Medical Center, Downey, CA 90242; and ∥Bioqual Incorporated, Rockville, MD 20850
-
Communicated by Robert H. Purcell, National Institutes of Health, Bethesda, MD (received for review August 6, 2002)
Abstract
The development of a subgenomic replicon derived from the hepatitis C virus (HCV) strain Con1 enabled the study of viral RNA replication in Huh-7 cells. The level of replication of replicons, as well as full-length Con1 genomes, increased significantly by a combination of two adaptive mutations in NS3 (E1202G and T1280I) and a single mutation in NS5A (S2197P). However, these cell culture-adaptive mutations influenced in vivo infectivity. After intrahepatic transfection of chimpanzees, the wild-type Con1 genome was infectious and produced viral titers similar to those produced by other infectious HCV clones. Repeated independent transfections with RNA transcripts of a Con1 genome containing the three adaptive mutations failed to achieve active HCV infection. Furthermore, although a chimpanzee transfected with RNA transcripts of a Con1 genome with only the NS5A mutation became infected, this mutation was detected only in virus genomes recovered from serum at day 4; viruses recovered at day 7 had a reversion back to the original Con1 sequence. Our study demonstrates that mutations that are adaptive for replication of HCV in cell culture may be highly attenuating in vivo.
Footnotes
-
↵ † To whom correspondence should be addressed. E-mail: jbukh{at}niaid.nih.gov.
- Abbreviations:
-
HCV, hepatitis C virus
-
HAV, hepatitis A virus
-
p.i., postinoculation
-
E, envelope
-
NS, nonstructural
-
ALT, alanine aminotransferase
-
- Copyright © 2002, The National Academy of Sciences
.gif?ad=15653&adview=true)





